The use of opioids for dyspnea in advanced disease

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 10, 2011, Pages 1170-

  Romayne, Gallagher ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CODEINE; DRUG METABOLITE; METHADONE; MORPHINE; OPIATE DERIVATIVE; OXYGEN; PETHIDINE;

ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; BREATHING RATE; COHORT ANALYSIS; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG TOLERABILITY; DYSPNEA; HOSPICE CARE; HUMAN; HYPOXIA; PROSPECTIVE STUDY; RESPIRATION DEPRESSION; SHORT SURVEY; TREATMENT RESPONSE;

EID: 79960192733     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj110024     Document Type: Article

References (5)

1. Clemens K E, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study. Support Care Cancer 2009;17:367-77.
2. Clemens KE, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioidnaive palliative care patients during symptomatic therapy of dyspnea with strong opioids? J Palliat Med 2008;11:204-16.
3. Portenoy RK, Sibirceva U, Smout R. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage 2006;32:532-40. (Pubitemid 44872928)
4. Somogyi AA, Barratt DT, Coller JK. Pharmacogenetics of opioids. Clin Pharmacol Ther 2007;81:429-44.
5. Smith HS. Opioid metabolism. Mayo Clin Proc 2009; 84:613-24.